These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4404052)

  • 41. Effects of beta-adrenoceptor blocking agents on haemodynamic parameters.
    Hansson L
    Acta Med Scand Suppl; 1977; 606():49-54. PubMed ID: 19930
    [No Abstract]   [Full Text] [Related]  

  • 42. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations].
    Bubiński R
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
    Bekes M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1972 Aug; 6(3):209-13. PubMed ID: 4405377
    [No Abstract]   [Full Text] [Related]  

  • 44. [Peripheral vascular effects of metoprolol, pindolol and propranolol in hypertensive patients].
    Joyal F; Bourque M; Kuchel O; Larochelle P
    J Pharmacol; 1983; 14 Suppl 2():107-15. PubMed ID: 6138462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical experience with bopindolol: summary of poster presentations.
    Ikeda M; Nakashima Y
    Am J Cardiol; 1991 Apr; 67(10):47B-50B. PubMed ID: 1673582
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluation of the acute hemodynamic and electrophysiologic effects of intravenous amlodipine alone and in combination with a beta-blocker in patients with angina pectoris.
    Vetrovec GW; Plumb V; Epstein AE; Kay GN
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S29-33. PubMed ID: 7522285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The inotropic and beta blocking effects of a chimeric molecule that putatively inhibits both type III phosphodiesterase and beta adrenoceptors in anesthetized dogs.
    Shaffer JE; Grizzle MK; Anderson DK; Wheeler TN
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1105-12. PubMed ID: 8099617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies].
    Mattioli G; Ricci S; Menozzi A; Teglio V
    Minerva Cardioangiol; 1982 Mar; 30(3):81-8. PubMed ID: 6123962
    [No Abstract]   [Full Text] [Related]  

  • 49. [Changes in some hemodynamic indices and the contractile state of the myocardium during infusion of dopamine in man].
    Di Segni E; Capestro F; Curzi G; Di Luzio V; Purcaro A; Soro A; Di Giuseppe F
    Boll Soc Ital Cardiol; 1971; 16(10):611-4. PubMed ID: 5147985
    [No Abstract]   [Full Text] [Related]  

  • 50. [The blood pressure profile, or how to establish the minimal effective dose of an antihypertensive agent].
    Abetel G
    Rev Med Suisse Romande; 1988 Jun; 108(6):529-33. PubMed ID: 2901140
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)].
    Reiterer W
    Wien Med Wochenschr; 1980 Dec; 130(23):772-7. PubMed ID: 6111161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative clinical and hemodynamic investigations on two beta-receptor blocking agents (pindolol and mepindolol) in normal subjects.
    Wink K
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):126-30. PubMed ID: 6715080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antihypertensive action of a beta-blocker: value of a controlled therapeutic trial].
    Safar M; Maiz HB; Weiss Y; Lagrue G; Milliez P
    Therapeutique; 1973; 49(7):459-62. PubMed ID: 4150742
    [No Abstract]   [Full Text] [Related]  

  • 54. Interaction between beta blockers and epinephrine on hemodynamics of spontaneously hypertensive rats.
    Kim Y
    Res Commun Chem Pathol Pharmacol; 1993 Apr; 80(1):3-19. PubMed ID: 8488340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of long-term administration of Pindolol (LB-46, Visken) in essential circulatory hyperkinesis. A double-blind, cross-over study.
    Békés M; Polák G; Istvánffy M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1974 Mar; 9(2):87-92. PubMed ID: 4208032
    [No Abstract]   [Full Text] [Related]  

  • 56. [Modification of isopropyl-noradrenaline-induced tachycardia through the effects of the beta blockaders: pindolol, practolol and SD/1601 in the conscious dog].
    Brusoni B; Marchetti G; Merlo L
    Boll Soc Ital Biol Sper; 1977 Mar; 53(6):450-4. PubMed ID: 20908
    [No Abstract]   [Full Text] [Related]  

  • 57. [Beta-blockers and arterial hypertension in the aged patient].
    Emeriau JP; Rumeau M
    Nouv Presse Med; 1978 Sep; 7(31):2803-6. PubMed ID: 30969
    [No Abstract]   [Full Text] [Related]  

  • 58. [Value of a single oral dose of pindolol].
    Safar M; Weiss Y; Milliez P
    Nouv Presse Med; 1978 Sep; 7(31):2767-8. PubMed ID: 30960
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of psycho-neurotic conversion reactions with pindolol. (Effect on cardio-vascular response to exercise).
    Kelesidis G; Hagis P; Samaras C
    Indian Heart J; 1972 Jun; 24():Suppl 1:238-43. PubMed ID: 4147280
    [No Abstract]   [Full Text] [Related]  

  • 60. [Cardiodepressive side effects of beta sympatholytic therapy. Clinical tests with Visken].
    Ohly A; König E; Nachreiner K; Schmidt F
    Med Klin; 1973 May; 68(19):628-34. PubMed ID: 4146864
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.